Publications by authors named "Emanuela Troiani"

Claim this Profile
U
Unmutated IGHV at diagnosis in patients with early stage CLL independently predicts for shorter follow-up time to first treatment (TTFT).
Piero Galieni, Emanuela Troiani, Paola Picardi, Mario Angelini, Francesca Mestichelli

Leuk Res· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The detection of circulating plasma cells may improve the Revised International Staging System (R-ISS) risk stratification of patients with newly diagnosed multiple myeloma.
Piero Galieni, Fosco Travaglini, Davide Vagnoni, Miriana Ruggieri, Patrizia Caraffa, Emanuela Troiani

Br J Haematol· May 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Array CGH analysis reveals deletion of chromosome 22q11 in CLL with normal karyotype and no fish alterations.
Francesca Mestichelli, Alessia Dalsass, Silvia Ferretti, Elisa Camaioni, Mario Angelini, Emanuela Troiani

Br J Haematol· October 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Circulating plasma cells in newly diagnosed symptomatic multiple myeloma as a possible prognostic marker for patients with standard-risk cytogenetics.
Davide Vagnoni, Fosco Travaglini, Valerio Pezzoni, Miriana Ruggieri, Catia Bigazzi, Emanuela Troiani

Br J Haematol· August 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mobilization-driven postconsolidation therapy in elderly patients with acute myeloid leukemia: feasibility and efficacy of autologous stem cell transplantation versus low-dose gemtuzumab ozogamicin.
Debora Capelli, Martina Chiarucci, Antonella Poloni, Francesco Saraceni, Giorgia Mancini, Emanuela Troiani

Biol Blood Marrow Transplant· September 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
6
6q deletion detected by fluorescence in situ hybridization using bacterial artificial chromosome in chronic lymphocytic leukemia.
Alessia Dalsass, Francesca Mestichelli, Miriana Ruggieri, Paola Gaspari, Valerio Pezzoni, Emanuela Troiani

Eur J Haematol· July 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A new intensive induction schedule, including high-dose Idarubicin, high-dose Aracytin and Amifostine, in older AML patients: feasibility and long-term results in 42 patients.
Attilio Olivieri, Debora Capelli, Emanuela Troiani, Antonella Poloni, Mauro Montanari

Exp Hematol· July 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A new schedule of CHOP/rituximab plus granulocyte-macrophage colony-stimulating factor is an effective rescue for patients with aggressive lymphoma failing autologous stem cell transplantation.
Attilio Olivieri, Moira Lucesole, Debora Capelli, Guido Gini, Mauro Montanari, Emanuela Troiani

Biol Blood Marrow Transplant· August 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis